Table 2.
Course of illness in Case 1 and Case 2. ARDS (Acute respiratory distress syndrome), mechanical ventilation (MV), Acute kidney injury (AKI), Deep venous thrombosis (DVT), Intravenous immunoglobulin (IVIg), Low molecular weight heparin (LMWH), Ventilator-associated pneumonia (VAP), Bloodstream infection (BSI), Catheter-associated urinary tract infection (CAUTI), Subarachnoid hemorrhage (SAH), Intravenous (IV)
| Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Week 9 | |
|---|---|---|---|---|---|---|---|---|---|
| Case 1 | |||||||||
| MV; Moderate-Severe ARDS (Berlin criteria) | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Proning | 6–7 sessions | 1 session for postural drainage of secretions | |||||||
| Vasopressors | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| AKI | Yes | Yes | |||||||
| Blood products | yes | yes | yes | yes | |||||
| Liver dysfunction | Yes | Yes | Yes | Yes | Yes | ||||
| Abdominal distension | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||
| DVT | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||
| Pancytopenia | Yes | Yes | Yes | Yes | Yes | ||||
| Virology workup | Bone marrow workup | ||||||||
| VAP | Yes | Yes | Yes | Yes | Yes | ||||
| BSI | Yes | Yes | Yes | ||||||
| CAUTI | Yes | Yes | Yes | ||||||
| Steroids | Yes | Yes | Yes | Yes | Yes | Yes | Yes | ||
| Remdesivir | Yes | ||||||||
| Antibiotics/antifungals | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes |
| Ganciclovir | Yes | Yes | Yes | ||||||
| IVIG for 5 days | IVIG | ||||||||
| LMWH/mechanical prophylaxis as feasible | |||||||||
| Outcome | Patient expired | ||||||||
| Case 2 | |||||||||
| SAH | SAH (not progressing) | ||||||||
| Room air; Hemodynamically stable Intermittent fever | |||||||||
| Pancytopenia | Yes | Yes | Yes | ||||||
| Hepatosplenomegaly | Yes | Yes | Yes | Yes | |||||
| Virology workup | |||||||||
| Tropical disease workup | Bone marrow workup | ||||||||
| NCCT Head | HRCT chest/NCCT abdomen and pelvis | MRI brain with MR angiography and MR venography (before discharge): no progression of SAH | |||||||
| IV/oral Acyclovir | Yes | Yes | |||||||
| IV/oral Doxycycline | Yes | ||||||||
| Iron replacement | Yes | Yes | |||||||
| Vitamin B12/Folic acid replacement | Yes | Yes | |||||||
| Anti-epileptic drugs | Yes | Yes | Yes | Yes | |||||
| Outcome | Patient discharged | ||||||||